Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion

Maplight Therapeutics (NASDAQ:MPLT) Coverage Initiated at TD Cowen

AI drug company starts chemical threat screening for defense

OVL: Your Chance To Outperform The S&P While Collecting A 10% Yield

UBS lowers 2026 S&P 500 target on Middle East conflict risks

New to The Street Signs Medicus Pharma Ltd. (NASDAQ:MDCX) to Transformational 12-Part National Media Series Highlighting SkinJect(TM) and Teverelix(R) Platforms